Thrombocytosis in an infant with high thrombopoietin concentrations

Area of Science:

• Hematology
• Pediatric Hematology
• Molecular Diagnostics

Background:

• Essential thrombocythemia (ET) is characterized by high platelet counts, typically with normal thrombopoietin (TPO) levels due to negative feedback.
• Familial ET cases can arise from TPO gene mutations leading to increased TPO production and subsequent thrombocytosis.
• Unexplained extreme thrombocytosis in children warrants investigation into underlying mechanisms beyond typical ET.

Observation:

• The study presents a case of an infant with extreme thrombocytosis (platelet count of 1300 x 10^3/mm^3) and concurrently elevated TPO concentrations.
• Genetic sequencing of the TPO gene in this infant did not reveal any causative mutations.

Findings:

• The infant responded successfully to treatment with anagrelide, a medication used to reduce platelet counts.
• This case suggests a potential diagnosis of atypical ET, where thrombocytosis might stem from TPO stimulation rather than traditional clonal proliferation.

Implications:

• Measuring TPO concentrations should be considered in the diagnostic workup for pediatric patients presenting with unexplained extreme thrombocytosis.
• This finding broadens the understanding of potential mechanisms underlying thrombocytosis in children, emphasizing the role of TPO levels beyond genetic mutations.